Valgimigli, Marco <br/><br/>
A strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction.  [electronic resource] 

 -  International journal of cardiology  Aug 2008 
 - 53-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1874-1754 
<br/><br/><label>Standard No.: </label>10.1016/j.ijcard.2007.05.021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Cost Control<br/>Cost-Benefit Analysis<br/>Drug-Eluting Stents--economics<br/>Female<br/>Hospital Costs<br/>Humans<br/>Immunoglobulin Fab Fragments--administration & dosage<br/>Immunosuppressive Agents--administration & dosage<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--mortality<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prospective Studies<br/>Sirolimus--administration & dosage<br/>Statistics, Nonparametric<br/>Stents--economics<br/>Tirofiban<br/>Treatment Outcome<br/>Tyrosine--administration & dosage